Oramed Pharmaceuticals Inc. (ORMP): Net earnings per share growth forecast for next year
The earnings per share growth forecast trend on GURU.Markets shows that 0.00 is the current metric. Oramed Pharmaceuticals (ORMP) attracts leading biochemists due to the uniqueness of its developments. Business stability is guaranteed by the patented POD system, which protects proteins in the gastrointestinal tract. Efficiency is enhanced through the robotization of dosing lines, which significantly reduces manual labor costs in the production of capsule insulin.
Analytical breakdowns and data insights for company Oramed Pharmaceuticals Inc. (ORMP)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
- net income and valuation ratios data:
ORMP - Final Profit|Expected Profit Oramed Pharmaceuticals|ORMP - Market Cap to Net Income|Forward P/E Multiple Oramed|ORMP - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Oramed Pharmaceuticals|ORMP - Operating profit EBITDA|Earnings per share for the last twelve months Oramed Pharmaceuticals|ORMP - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months oramed.com|ORMP - Net earnings per share growth this year|Earnings growth forecast for next year Oramed Pharmaceuticals
- total revenue and sales volume data:
Comprehensive company analysis:Oramed Pharmaceuticals, ORMP
Oramed Pharmaceuticals profit dynamics are sensitive to external market shocks and competition in the US. However, strong liquidity and Nadav Kidron's strategic approach create a substantial margin of safety for the business. By analyzing the projected EPS growth rate for next year, an investor assesses analyst consensus expectations, which allows for the timely detection of shifts in institutional sentiment and a reassessment of the asset's risks.
Competitors of Oramed Pharmaceuticals
HLN (Haleon Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Kenvue Health KVUE|Net earnings per share growth forecast for next year Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Ligand LGND|Amneal Pharmaceuticals, Inc. (AMRX) - Expected net earnings per share growth next year|PRGO - Net earnings per share growth forecast for next year|Expected earnings per share trend next year ALVO (Alvotech Biopharmaceuticals)|LQDA: Earnings growth forecast for next year|glpg.com (GLPG) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year ANI Pharmaceuticals, Inc.|Expected earnings per share growth for next year MannKind Corp (MNKD)|Earnings growth forecast for next year AMPH|PCRX - Expected net earnings per share growth next year|Earnings growth forecast for next year SPRY (ARS Pharmaceuticals)|TBPH: Projected earnings per share growth rate for next year|AQST: Expected earnings per share growth for next year|Expected earnings per share trend next year SCPH (scPharmaceuticals Inc.)|tectonictx.com (TECX) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year TNXP (Tonix Pharmaceuticals Holding)|SXTC (SXT Pharmaceuticals) - Earnings growth forecast for next year|EPRX: Expected earnings per share trend next year|Earnings growth forecast for next year BHST|Earnings growth forecast for next year Invizyne Technologies (EXOZ)|Net earnings per share growth forecast for next year Entera Bio ENTX|Expected earnings per share trend next year HYFT|ABVC - Net earnings per share growth forecast for next year|cumberlandpharma.com (CPIX) - Expected earnings per share growth for next year|QNTM: Earnings growth forecast for next year|FibroGen Inc (FGEN) - Earnings growth forecast for next year|TELO (Telomir Pharma) - Earnings growth forecast for next year|Expected earnings per share growth for next year Rani Therapeutics Inc (RANI)|Earnings growth forecast for next year SNYR|RLYB - Expected net earnings per share growth next year|Lexaria Bioscience Corp. - Expected earnings per share growth for next year|Earnings growth forecast for next year Pulmatrix Inc PULM|PTHL: Expected earnings per share growth for next year|Aptorum Group Limited - Projected earnings per share increase next year|LYRA: Earnings growth forecast for next year|IBO - Consensus forecast of earnings per share growth for next year|TNFA (TNF Pharmaceuticals Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year cbdMD Corp (YCBD)|Earnings growth forecast for next year PRFX|Earnings growth forecast for next year altamiratherapeutics.com (CYTO)|Net earnings per share growth forecast for next year Lipella Pharmaceuticals LIPO|optinose.com - Net earnings per share growth forecast for next year|PIRS - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Procaps Group PROC|Petros (PTPI) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Qilian International Corp (QLI)|Net earnings per share growth forecast for next year Acelyrin, Inc.|TFFP: Expected earnings per share trend next year
